| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0028-3908(90)90024-L |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:002839089090024L?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:002839089090024L?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 1696701 |
| P50 | author | Kenji Hashimoto | Q70911404 |
| P2093 | author name string | T. Goromaru | |
| P2860 | cites work | 5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders | Q48184344 |
| Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats | Q48192149 | ||
| Aminergic systems in Alzheimer's disease and Parkinson's disease | Q48225859 | ||
| Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen | Q48363578 | ||
| Characterization of [3H]paroxetine binding to rat cortical membranes | Q48435025 | ||
| Tryptophan hydroxylase activity and synaptosomal uptake of serotonin in discrete brain regions after midbrain raphe lesions: Correlations with serotonin levels and histochemical fluorescence | Q48727187 | ||
| Tritiated imipramine binding sites are decreased in the frontal cortex of suicides | Q48932476 | ||
| Decreased imipramine binding in the brains of patients with depressive illness. | Q53309673 | ||
| Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine) | Q53964175 | ||
| Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity. | Q54618281 | ||
| Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine | Q68767743 | ||
| In vivo labeling of serotonin uptake sites with [3H]paroxetine | Q69298834 | ||
| Protein measurement with the Folin phenol reagent | Q20900776 | ||
| Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Q27860958 | ||
| The background and chemistry of MDMA. | Q34682879 | ||
| Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain | Q42506514 | ||
| Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons | Q43736886 | ||
| Stereochemistry of the metabolism of MDMA to MDA. | Q45009569 | ||
| MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons | Q48121118 | ||
| Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. | Q48179859 | ||
| Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine | Q48180215 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 633-639 | |
| P577 | publication date | 1990-07-01 | |
| P1433 | published in | Neuropharmacology | Q15332439 |
| P1476 | title | Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-methylenedioxymethamphetamine | |
| P478 | volume | 29 |
Search more.